Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine + PCA for post‑thoracoscopic analgesia
ChiCTR2500115389Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchial carcinoma and postoperative pain comparing Liposomal bupivacaine infiltration with Ropivacaine infiltration plus PCA (2 arms). Primary endpoint: Peak pain score within 24 hours postoperatively. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
bronchial carcinomapostoperative pain
Beyond the preview
Go deeper on ChiCTR2500115389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115389.